Relapsing Polychondritis with Meningoencephalitis Refractory to Immunosuppressant Therapy

Meningoencephalitis is a rare complication of relapsing polychondritis. We report a case of a 25-year-old male who presented with visual hallucinations and symptoms of depression and anxiety, white matter changes on MRI, and CSF lymphocytosis, along with inflammatory chondritis seen in his auricle c...

Full description

Bibliographic Details
Main Authors: Mohammad Mousbah Al-Tabbaa, Hani Habal
Format: Article
Language:English
Published: Hindawi Limited 2018-01-01
Series:Case Reports in Neurological Medicine
Online Access:http://dx.doi.org/10.1155/2018/1873582
id doaj-3a11b03f81f845ea9e60a354c8fdff61
record_format Article
spelling doaj-3a11b03f81f845ea9e60a354c8fdff612020-11-24T23:57:26ZengHindawi LimitedCase Reports in Neurological Medicine2090-66682090-66762018-01-01201810.1155/2018/18735821873582Relapsing Polychondritis with Meningoencephalitis Refractory to Immunosuppressant TherapyMohammad Mousbah Al-Tabbaa0Hani Habal1Visiting MD, University of Illinois College of Medicine at Peoria, Peoria, IL, USAClinical Assistant Professor, University of Illinois College of Medicine at Peoria, Peoria, IL, USAMeningoencephalitis is a rare complication of relapsing polychondritis. We report a case of a 25-year-old male who presented with visual hallucinations and symptoms of depression and anxiety, white matter changes on MRI, and CSF lymphocytosis, along with inflammatory chondritis seen in his auricle cartilage biopsy. Eventually he was given the diagnosis of RP presenting with meningoencephalitis based on CSF analysis, brain MRI findings, negative serologies, and neurologic exam findings. The patient’s clinical state did not improve despite being on IV methylprednisolone for a period of 7 days; afterwards he was switched to oral prednisone with no clinical improvement. As a result, he was given cyclophosphamide and rituximab, respectively, without benefit. He also underwent craniectomy with VP shunt due to worsening hydrocephalus and a brain biopsy was done to confirm the diagnosis. He is currently on methotrexate and steroid dependent with a goal to taper down. Even though all 19 reported cases of meningoencephalitis with RP in the literature did respond to immunosuppressive therapy, in our case, however the patient did not respond to immunosuppressive treatment and currently is in mute dementia status after three years of treatment.http://dx.doi.org/10.1155/2018/1873582
collection DOAJ
language English
format Article
sources DOAJ
author Mohammad Mousbah Al-Tabbaa
Hani Habal
spellingShingle Mohammad Mousbah Al-Tabbaa
Hani Habal
Relapsing Polychondritis with Meningoencephalitis Refractory to Immunosuppressant Therapy
Case Reports in Neurological Medicine
author_facet Mohammad Mousbah Al-Tabbaa
Hani Habal
author_sort Mohammad Mousbah Al-Tabbaa
title Relapsing Polychondritis with Meningoencephalitis Refractory to Immunosuppressant Therapy
title_short Relapsing Polychondritis with Meningoencephalitis Refractory to Immunosuppressant Therapy
title_full Relapsing Polychondritis with Meningoencephalitis Refractory to Immunosuppressant Therapy
title_fullStr Relapsing Polychondritis with Meningoencephalitis Refractory to Immunosuppressant Therapy
title_full_unstemmed Relapsing Polychondritis with Meningoencephalitis Refractory to Immunosuppressant Therapy
title_sort relapsing polychondritis with meningoencephalitis refractory to immunosuppressant therapy
publisher Hindawi Limited
series Case Reports in Neurological Medicine
issn 2090-6668
2090-6676
publishDate 2018-01-01
description Meningoencephalitis is a rare complication of relapsing polychondritis. We report a case of a 25-year-old male who presented with visual hallucinations and symptoms of depression and anxiety, white matter changes on MRI, and CSF lymphocytosis, along with inflammatory chondritis seen in his auricle cartilage biopsy. Eventually he was given the diagnosis of RP presenting with meningoencephalitis based on CSF analysis, brain MRI findings, negative serologies, and neurologic exam findings. The patient’s clinical state did not improve despite being on IV methylprednisolone for a period of 7 days; afterwards he was switched to oral prednisone with no clinical improvement. As a result, he was given cyclophosphamide and rituximab, respectively, without benefit. He also underwent craniectomy with VP shunt due to worsening hydrocephalus and a brain biopsy was done to confirm the diagnosis. He is currently on methotrexate and steroid dependent with a goal to taper down. Even though all 19 reported cases of meningoencephalitis with RP in the literature did respond to immunosuppressive therapy, in our case, however the patient did not respond to immunosuppressive treatment and currently is in mute dementia status after three years of treatment.
url http://dx.doi.org/10.1155/2018/1873582
work_keys_str_mv AT mohammadmousbahaltabbaa relapsingpolychondritiswithmeningoencephalitisrefractorytoimmunosuppressanttherapy
AT hanihabal relapsingpolychondritiswithmeningoencephalitisrefractorytoimmunosuppressanttherapy
_version_ 1725453944830820352